Targeted Medical Pharma Finalizes Exclusive Agreement for Distribution in CHINA

Los Angeles – Targeted Medical Pharma (OTCQB: TRGM), today announced the completion of an exclusive product licensing agreement with Healthy Focus Limited, a Hong Kong based company that specializes in distributing healthcare products throughout China. The Agreement grants Healthy Focus an exclusive three-year renewable license for the marketing and sale of Theramine®, Percura™ and Trepadone® in Hong Kong and China. Under the terms of the Agreement, Healthy Focus is responsible for registering all products in China, an initial licensing fee as well as maintaining annual Continue reading →

Targeted Medical Pharma Announces Changes in Management and Board of Directors

New Management Structure Positions Company for Growth and Profitability Los Angeles, CA, January 29, 2015 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced several major changes that streamline operations and signify a commitment to revenue growth, cost containment and profitability. The Company has appointed Kim Giffoni, a co-founder and former Vice President of Foreign Sales at Targeted Medical Pharma, as the Chief Executive Officer. Dr. David Silver, former Chief Operating Officer and President at the Company, has been appointed Chief Medical Officer, and Marcus Continue reading →

Targeted Medical Pharma, Inc. Announces Q3 Financial Results and Clinical Program Updates

Los Angeles, CA, November 18, 2014 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) a drug discovery and development biotechnology company, today announced financial results for its third quarter ended September 30, 2014 and clinical trial updates. The company reported significant improvement in both net loss and net loss before interest, taxes, depreciation and amortization, and stock based compensation (Adjusted EBITDA*) on a quarter-over-quarter basis. In Addition, in Q3, the company reported major advances in the development of new treatments for both chronic low back pain Continue reading →

Targeted Medical Pharma’s New Approach to Pain Management Targets Epidemic of Opioid and NSAID Over-Prescribing

White Paper explores Theramine® as a Safe and Clinically Effective Alternative to Common Pain Medications  Los Angeles, CA, October 6, 2014 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), recently published the White Paper: Innovations in Pain Management discussing the epidemic of pain, the dangers of commonly prescribed pain medications and the benefits of Theramine, as a clinically effective alternative to opioids and nonsteroidal anti-inflammatory (NSAID) drugs for the management of back pain and inflammation. According to Consumer Reports, the overuse of opioid pain medications has reached epidemic Continue reading →

Targeted Medical Pharma to Present at 2013 Southern California Investor Conference

Los Angeles, CA, August 6th, 2013 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies for the treatment of chronic disease, today announced that the company’s CEO and Chief Science Officer William Shell, M.D., will be presenting at the 2013 Southern California Investor Conference being held at the Island Hotel in Newport Beach, California on Thursday, August 8, 2013 at 8:30 a.m. PST. Interested parties may listen to Continue reading →

Physician Therapeutics to Host Webcast on Medical Foods in Clinical Practice

Expert Panel of Doctors to Discuss Clinical Data on Safety and Efficacy of Medical Foods in Pain Management and Sleep Disorders Los Angeles, June 19, 2012 – Physician Therapeutics, Inc., a division of Targeted Medical Pharma, Inc., will host a live webcast and conference call titled “Medical Foods in Clinical Practice,” to be held on Friday, June 29, starting at noon PST. Media, physicians, clinicians and other medical industry personnel interested in the safety and efficacy of medical foods in pain management and sleep disorders Continue reading →

Clinical Trial Shows Theramine® is Safe and Effective for Chronic Back Pain

Los Angeles, June 11, 2012 – Physician Therapeutics, Inc., a division of Targeted Medical Pharma, Inc., a  specialty pharmaceutical company that  develops and distributes specialty pharmaceuticals to physicians, pharmacies and skilled nursing facilities, published results from a clinical trial of the company’s proprietary medical food Theramine®. The trial demonstrated improvement in chronic low back pain in 129 subjects when administered as a standalone therapy or in conjunction with low dose naproxen for 28 days.  The results of this study have been published in the March Continue reading →

Clinical Trial Shows Sentra PM® Improves Quality of Sleep

Los Angeles, May 2, 2012 – Physician Therapeutics, Inc., a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that  manufactures and distributes specialty pharmaceuticals to physicians, pharmacies and skilled nursing facilities, published results from a clinical trial of the proprietary medical food Sentra PM.  This trial demonstrated improved sleep latency and improved nighttime parasympathetic nervous system activity as a standalone medication or used in conjunction with a low dose of Trazadone. The results of this study have been published in the May issue Continue reading →

Physician Therapeutics to Exhibit April 23-26, 2012 in San Diego, CA

Physician Therapeutics, a division of Targeted Medical Pharma Inc. will be exhibiting at the Freedom and Recovery, Integrated Mental Health and Addiction Treatment Conference for serivce memebers and first responders, April 23-26, 2012 at the Hotel del Coronado in San Diego, CA. The exhibit will feature updated clinical data regarding the nutritional management of PTSD and Gulf War Illness as well multimodal nonaddicitive treatment options for pain syndromes.

Targeted Medical Pharma Exhibits at the 2011 JFPS in Dallas, Texas

Los Angeles, CA, November 14, 2011 Targeted Medical Pharma Inc. which develops and sells medical food products through its subsidiary Physician Therapeutics, exhibited product information and technology related to its medical foods addressing pain management and sleep disorders related to Post Traumatic Stress Disorder to over 2000 active and retired United States Military pharmacists, service men and women at the Joint Forces Pharmacy Seminar in Dallas, Texas from October 31-November 3, 2011. Other exhibitors included Takeda, Teva Neuroscience, Pfizer, GlaxoSmithKilne, Endo Pharmaceuticals and Express Scripts.   About Targeted Medical Pharma, Inc. Targeted Medical Continue reading →